NH Nongwoobio KRX:054050KOSDAQ
농우바이오 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days1
DART filings, 7 days1
Articles tracked11since Sep 11
In Q2 2026, NH Nongwoobio reported revenue of ₩46.1bn, up 6.3% year on year, and operating profit of ₩2.5bn. NH Nongwoobio (농우바이오) appeared in 1 Korean news article and 1 DART filing over the past seven days. Coverage peaked on Sep 30 with 9 articles. The most common catalyst was risk & warnings (1).
Filing signals Dividend grower Screener
NH Nongwoobio quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩46.1bn | +6.3% | ₩2.5bn margin 5.4% | ₩3.2bn |
| Q1 2026 | ₩36.4bn | -2.7% | ₩5.4bn margin 14.8% | ₩6.4bn |
| Q4 2025 derived | ₩39.2bn | +24.7% | −₩851m margin −2.2% | −₩1.1bn |
| Q3 2025 | ₩38.9bn | -1.1% | ₩3.7bn margin 9.6% | ₩4.3bn |
| Q2 2025 | ₩43.3bn | +7.1% | ₩3.2bn margin 7.4% | ₩2.6bn |
| Q1 2025 | ₩37.4bn | +11.7% | ₩7.6bn margin 20.2% | ₩6.5bn |
| Q4 2024 derived | ₩31.4bn | +3.8% | −₩2.1bn margin −6.6% | −₩224m |
| Q3 2024 | ₩39.3bn | +2.7% | ₩6.5bn margin 16.6% | ₩3.3bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
NH Nongwoobio top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
- 5
- 6
Latest NH Nongwoobio news Korean headlines
-
농협경제지주, 종자사업 ‘NH농우바이오’ 중심 통합
3 more on this story · 3 outlets
- 농협경제지주, NH농우바이오 중심 종자사업 통합뉴시스경제 · Sep 30 14:02
- 농협경제지주, 종자사업 'NH농우바이오'로 전면 통합뉴스락 · Sep 30 17:13
- 농협경제지주, 종자사업 농우바이오 중심 통합글로벌뉴스통신GNA · Sep 30 18:37
-
농협, 종자사업 통합 추진…NH농우바이오 중심 글로벌 경쟁력 강화
1 more on this story · 1 outlets
- 농협경제지주, NH농우바이오 중심 종자사업 통합…"글로벌 경쟁력 제고"글로벌경제신문 · Sep 30 14:15